Patrick Cashman is president of USAntibiotics, the sole licensed American manufacturer of amoxicillin-based Augmentin and Amoxil solid, oral beta-lactam antibiotics and authorized generics. Based in Tennessee, he leads the team of R&D, quality, manufacturing, regulatory affairs, supply chain and commercial professionals who operate from the company’s world-class, 394,000 square foot production facility that can produce and fulfill 100 percent of the nation’s demand for these essential, life-saving medications.
With three decades in the industry, Patrick has served in executive management positions in multinational pharmaceutical organizations in the U.S., Canada and Mexico. With a focus on growth, quality and innovation, he is recognized for his knowledge and industry experience, commitment to operational excellence, delivery of exceptional client support and cultivation of high-performance teams. During his career – which includes senior leadership positions at Lundbeck, Pfizer and SmithKline Beecham – he established new subsidiaries in key markets, launched new pharmaceutical brands and led co-commercialization teams with partners around the world.
Patrick has received numerous awards, including international honors for profitability, sales growth, innovation and a new oncology business unit, while at Lundbeck Canada. His focus on patient centricity earned him the Eye for Pharma Lifetime Achievement Award. He also champions mental health awareness, having presented at the Champions of Mental Health Awards and to members of the Canadian Parliament. Patrick holds an MBA from Thunderbird School of International Business at Arizona State University and Bachelor of Science in Economics degree from the University of Wisconsin.
